Galapagos and GlaxoSmithKline announced they have reached an agreement for Galapagos to acquire GSK's state-of-the art research centre in Zagreb, Croatia. The arrangement, which is subject to closing conditions and is expected to be effective as of 9 September 2010, provides for ongoing employment more
To use all functions of this page, please activate cookies in your browser.